MYC and lung cancer: The reduction in METTL3 expression mediated by miR‐338‐5p disrupts nuclear oncogene c‐Myc‐mediated m6A modifications, leading to decreased expression of c‐Myc and consequent suppression of the proliferation, invasion, and migration of lung cancer cells.130